DEXA — Bone Density & Body Composition
Last reviewed 25 August 2026 · Evidence-graded review — see Methodology
One machine sold for two quite different purposes, which is the source of most of the confusion around it. Dual-energy X-ray absorptiometry measures bone mineral density — its original, guideline-endorsed use — and also whole-body composition: fat mass, lean mass, and a modelled estimate of visceral adipose tissue. Osteoporosis is common, silent until fracture, and treatable. Visceral fat drives insulin resistance, dyslipidaemia and hepatic inflammation through portal free-fatty-acid and cytokine release. The two use cases do not carry the same weight of evidence, and packages rarely separate them.
The bone density use case is genuinely Strong: well-validated fracture-risk prediction, guideline-endorsed for screening postmenopausal women and older men. The body-composition use case marketed in longevity packages is weaker. Visceral fat measured directly by CT is an independent predictor of all-cause mortality in men, but the VAT figure a DEXA returns is a modelled estimate derived from 2D imaging rather than a direct volumetric measurement, with acknowledged limits in distinguishing visceral from other trunk fat depots compared with CT or MRI. It is a reasonable, low-radiation proxy for tracking change over time — read the specific VAT number as an estimate, not a precise clinical figure.
Visceral fat and mortality: PubMed: PMID 16571861 (Kuk JL, et al., "Visceral fat is an independent predictor of all-cause mortality in men") · Full cost breakdown & bone density vs body composition →
Singapore guidance
- Bone density Recommended for higher-risk groups only
- Body composition Not recommended for screening
For bone density, Singapore’s national screening committee treats DEXA as a high-risk test, not a population screen — risk is assessed first (OSTA for Asian women from 50, clinical assessment for men from 65) and the scan follows only if that assessment indicates it. For body composition, body-fat measurement is listed as not recommended for screening; BMI and waist circumference are the recommended measures.
Source: Screening Test Review Committee report 2026, Volume 1 (Academy of Medicine Singapore and Ministry of Health, February 2026), Tables 2E(i), 2E(iia), 2E(iib), 2D(i). The full national list · How this is used.
What you would actually pay
- Healthier SG
- Not subsidised
- MediSave
- Not among the screenings named for outpatient claims
Source: Healthier SG Screening (HealthHub) and MediSave outpatient care (Ministry of Health). Absence from either list is not a statement that the test is discouraged — only that no subsidy or claim applies. Gross prices compared.
What it costs when it is wrong
- Basis
- No published harm criterion found
- Severity
- Not documented
No published harm criterion found for this test.
An empty finding, not a clean bill of health: this means nothing documented was found for this test. It is not a claim that the test is safe.
Screening harm is not only a laboratory question: the committee’s own criteria advise against a test when “the screening test, or follow-up tests arising from a positive screen, are associated with significant medical risks”. Sources on overdiagnosis → · How this is graded.
For bone density, the committee’s first step is a risk score, not a scan: work out your OSTA score →
Singapore pricing. We have a full price breakdown for this test, using checked 2026 figures from named providers — read the price guide →
FAQ
Is the DEXA — Bone Density & Body Composition worth doing in Singapore?
Judged for screening an asymptomatic adult, DEXA — Bone Density & Body Composition grades moderate on our rubric. It is most appropriate for bone density: in Singapore, women from 50 or menopause whose OSTA risk score points to a scan, and men from 65 after a clinical risk assessment. Body composition: not recommended for screening by Singapore's committee, which uses BMI and waist circumference instead; some use it to track fat and lean mass over time. It typically costs S$140–310 in Singapore. Two schedules apply: bone density: risk reassessed every 5 years, with a scan only when the assessment indicates one. Body composition: optional, every 6–12 months if tracking a fitness programme.
Weighing this against something else? Compare it with two other tests → · Price it inside a panel →